Quick Answer
CytoDyn Inc. reported Shares Outstanding of 1.25 billion shares for fiscal year 2025.
CytoDyn Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.25B | +18.0% |
| 2024 | 1.06B | +15.2% |
| 2023 | 918.61M | +27.7% |
| 2022 | 719.59M | +15.0% |
| 2021 | 625.68M | +20.6% |
| 2020 | 518.98M | +57.6% |
| 2019 | 329.40M | +52.0% |
| 2018 | 216.72M | +45.0% |
| 2017 | 149.47M | +21.2% |
| 2016 | 123.34M | +93.8% |
| 2015 | 63.64M | +14.2% |
| 2014 | 55.75M | +80.4% |
| 2013 | 30.91M | +7.9% |
| 2012 | 28.64M | +28.5% |
| 2011 | 22.29M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | 1.27B | +3.5% | +0.7% |
| August 31, 2025 | 1.26B | +3.0% | +0.6% |
| May 31, 2025 | 1.25B | +18.0% | +1.4% |
| February 28, 2025 | 1.23B | +24.5% | +0.8% |
| November 30, 2024 | 1.22B | +25.9% | +0.3% |
| August 31, 2024 | 1.22B | +31.0% | +15.2% |
| May 31, 2024 | 1.06B | +15.2% | +6.9% |
| February 29, 2024 | 989.92M | +18.3% | +1.9% |
- CytoDyn Inc. showed an increase of +18.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, CytoDyn Inc.’s shares outstanding has grown by 5503.9% (from 22.29 million shares to 1.25 billion shares).
- The most recent figure is from CytoDyn Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: